-
Signature
-
/s/ Gregory Weaver, as Attorney-in-Fact
-
Issuer symbol
-
ALT
-
Transactions as of
-
27 Jan 2026
-
Net transactions value
-
-$29,343
-
Form type
-
4
-
Filing time
-
29 Jan 2026, 16:05:07 UTC
Quoteable Key Fact
"M. Scot Roberts filed Form 4 for Altimmune, Inc. (ALT) on 29 Jan 2026."
Quick Takeaways
- This page summarizes M. Scot Roberts's Form 4 filing for Altimmune, Inc. (ALT).
- 3 reported transactions and 1 derivative row are listed below.
- Filing timestamp: 29 Jan 2026, 16:05.
What Changed
- Previous filing in this sequence was filed on 27 Jan 2026.
- Current net transaction value: -$29,343.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Roberts M Scot |
Chief Scientific Officer |
910 CLOPPER ROAD, SUITE 201S, GAITHERSBURG |
/s/ Gregory Weaver, as Attorney-in-Fact |
29 Jan 2026 |
0001705905 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
ALT |
Common Stock, par value $0.0001 |
Options Exercise |
$0 |
+15,850 |
+19% |
$0.000000 |
100,143 |
27 Jan 2026 |
Direct |
F1 |
| transaction |
ALT |
Common Stock, par value $0.0001 |
Tax liability |
$29,343 |
-4,748 |
-4.7% |
$6.18 |
95,395 |
27 Jan 2026 |
Direct |
F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
ALT |
Restricted Stock Units |
Options Exercise |
$0 |
-15,850 |
-25% |
$0.000000 |
47,550 |
27 Jan 2026 |
Common Stock, par value $0.0001 |
15,850 |
|
Direct |
F1, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses: